Winrevair 45MG - emergency pharmaceutical
Ended Awarded Last action
- Contract number
- 36C26126N0351
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,388
Award facts
- Contract value 100% obligated
- $21,388.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rahway, NJ 07065, USA
Award details come from SAM.gov/FPDS.
About this award
On February 27, 2026, the Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a delivery order to Merck Sharp & Dohme LLC for WINREVAIR 45MG, an emergency pharmaceutical product. This $21,388.30 firm fixed-price delivery order, with a completion date of March 13, 2026, was issued under Merck's existing $5.84 billion Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with the VA, which runs through May 31, 2030. The procurement was not subject to any set-aside designation and will be performed in Rahway, New Jersey, where Merck maintains a significant manufacturing and distribution presence.
WINREVAIR (sotatercept-csrk) is a specialty therapeutic used in the treatment of pulmonary hypertension. This delivery order reflects the VA's utilization of its master pharmaceutical supply agreement with Merck to procure emergency medications for veterans within the network. Merck has established itself as a critical pharmaceutical supplier to federal healthcare agencies, providing an extensive portfolio of vaccines, specialty therapeutics, and medical countermeasures. The FSS-61-IB contract serves as a flexible procurement mechanism enabling the VA to maintain responsive access to pre-negotiated pharmaceutical products while benefiting from established pricing and supplier relationships that ensure continuity of care across the federal healthcare system.
Quick answers
Who was awarded contract 36C26126N0351?
36C26126N0351 was awarded to Merck Sharp & Dohme LLC by Veterans Integrated Service Network 21 (Veterans Health Administration) on February 27, 2026.
How much is contract 36C26126N0351 worth?
The government has obligated $21,388 on 36C26126N0351.
Is contract 36C26126N0351 an order under another contract?
Yes. 36C26126N0351 is a delivery order under 36F79725D0146, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26126N0351 competed?
The extent of competition for 36C26126N0351 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award